Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Ferring Microbiome Inc. manages 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are assigned to distinct art units, indicating a varied technical scope for the company's current filings.
The prosecution involves 2 distinct examiners, which means each case is being reviewed by a different individual. The busiest examiner, GRASER, JENNIFER E, is responsible for 1 pending office action. This 1 pending office action represents the standard workload for examiners currently assigned to the portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Double-patenting only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GRASER, JENNIFER E | 1 | 76.8% | +23.2% |
| BERKE-SCHLESSEL, DAVID W | 1 | 66.8% | +31.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18793525 | MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITION AND METHODS OF MANUFACTURE | GRASER, JENNIFER E | — |
| 18136213 | MICROBIOTA RESTORATION THERAPY (MRT) COMPOSITIONS AND METHODS OF MANUFACTURE | BERKE-SCHLESSEL, DAVID W | — |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18793525 | MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITION AND METHODS OF MANUFACTURE | GRASER, JENNIFER E | 1645 | DP | Non-Final OA | — | Pending | Aug 02, 2024 |
| 18136213 | MICROBIOTA RESTORATION THERAPY (MRT) COMPOSITIONS AND METHODS OF MANUFACTURE | BERKE-SCHLESSEL, DAVID W | 1651 | §103 | Final Rejection | — | Pending | Apr 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFerring Microbiome Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Jennifer E Graser has the most, with 1 of Ferring Microbiome Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
